These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15944943)

  • 1. The "early birds": natural IgM antibodies and immune surveillance.
    Vollmers HP; Brändlein S
    Histol Histopathol; 2005 Jul; 20(3):927-37. PubMed ID: 15944943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural antibodies and cancer.
    Vollmers HP; Brändlein S
    J Autoimmun; 2007 Dec; 29(4):295-302. PubMed ID: 17826951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural antibodies and cancer.
    Vollmers HP; Brändlein S
    N Biotechnol; 2009 Jun; 25(5):294-8. PubMed ID: 19442595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Death by stress: natural IgM-induced apoptosis.
    Vollmers HP; Brandlein S
    Methods Find Exp Clin Pharmacol; 2005 Apr; 27(3):185-91. PubMed ID: 15834451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural IgM antibodies, the ignored weapons in tumour immunity.
    Brändlein S; Vollmers HP
    Histol Histopathol; 2004 Jul; 19(3):897-905. PubMed ID: 15168352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural IgM antibodies and immunosurveillance mechanisms against epithelial cancer cells in humans.
    Brändlein S; Pohle T; Ruoff N; Wozniak E; Müller-Hermelink HK; Vollmers HP
    Cancer Res; 2003 Nov; 63(22):7995-8005. PubMed ID: 14633732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective autoimmunity in cancer (review).
    Toubi E; Shoenfeld Y
    Oncol Rep; 2007 Jan; 17(1):245-51. PubMed ID: 17143505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural human immunoglobulins in cancer immunotherapy.
    Vollmers HP; Brändlein S
    Immunotherapy; 2009 Mar; 1(2):241-8. PubMed ID: 20635944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of natural and immune IgM antibodies in immune responses.
    Boes M
    Mol Immunol; 2000 Dec; 37(18):1141-9. PubMed ID: 11451419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural monoclonal antibodies and cancer.
    Vollmers PH; Brändlein S
    Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):84-7. PubMed ID: 18537750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drivers and regulators of humoral innate immune responses to infection and cancer.
    Kumar D; Romero Y; Schuck KN; Smalley H; Subedi B; Fleming SD
    Mol Immunol; 2020 May; 121():99-110. PubMed ID: 32199212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoptosis: tumor-specific cell death by antibody-induced intracellular lipid accumulation.
    Pohle T; Brändlein S; Ruoff N; Müller-Hermelink HK; Vollmers HP
    Cancer Res; 2004 Jun; 64(11):3900-6. PubMed ID: 15173000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine-rich fibroblast growth factor receptor 1, a new marker for precancerous epithelial lesions defined by the human monoclonal antibody PAM-1.
    Brändlein S; Beyer I; Eck M; Bernhardt W; Hensel F; Müller-Hermelink HK; Vollmers HP
    Cancer Res; 2003 May; 63(9):2052-61. PubMed ID: 12727819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAM-1, a natural human IgM antibody as new tool for detection of breast and prostate precursors.
    Brändlein S; Eck M; Ströbel P; Wozniak E; Müller-Hermelink HK; Hensel F; Vollmers HP
    Hum Antibodies; 2004; 13(4):97-104. PubMed ID: 15719499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does a "thiol shield" protect tumors from natural IgM antibody, and, if so, how can it be suppressed?
    Jones PC
    Med Hypotheses; 2013 Apr; 80(4):425-30. PubMed ID: 23375413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancer.
    Rettig TA; Harbin JN; Harrington A; Dohmen L; Fleming SD
    Clin Immunol; 2015 Oct; 160(2):244-54. PubMed ID: 26145788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patients.
    Brändlein S; Lorenz J; Ruoff N; Hensel F; Beyer I; Müller J; Neukam K; Illert B; Eck M; Müller-Hermelink HK; Vollmers HP
    Hum Antibodies; 2002; 11(4):107-19. PubMed ID: 12775891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (Review).
    Díaz-Zaragoza M; Hernández-Ávila R; Viedma-Rodríguez R; Arenas-Aranda D; Ostoa-Saloma P
    Oncol Rep; 2015 Sep; 34(3):1106-14. PubMed ID: 26133558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural IgM and innate immune collectin SP-D bind to late apoptotic cells and enhance their clearance by alveolar macrophages in vivo.
    Litvack ML; Djiadeu P; Renganathan SD; Sy S; Post M; Palaniyar N
    Mol Immunol; 2010; 48(1-3):37-47. PubMed ID: 21035192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison patterns of 4 T1 antigens recognized by humoral immune response mediated by IgG and IgM antibodies in female and male mice with breast cancer using 2D-immnunoblots.
    Díaz-Zaragoza M; Hernández-Ávila R; Govezensky T; Mendoza L; Meneses-Ruíz DM; Ostoa-Saloma P
    Immunobiology; 2015 Sep; 220(9):1050-8. PubMed ID: 26026196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.